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INTRODUCTION
Adenocarcinoma currently accounts for 10–25% of all 
uterine cervical carcinomas in developed countries (1), 
and its incidence just keeps increasing according to a 
decrease in the incidence of squamous cell carcinoma (SCC) 
as a result of improved screening programs (1-3). Recent 
studies suggest that high-risk human papillomavirus (HPV) 
types 16, 18, and 45 are responsible for approximately 70% 
SCCs and 80% adenocarcinomas (Table 1) (1, 4, 5). The 
overall prognosis of adenocarcinomas is similar to or slightly 
poorer than that of SCC; however, the prognosis of each 
adenocarcinoma varies with its histopathological type (1-7). 
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Cervical tumor is evaluated by several imaging modalities, 
and it has been reported that SCC tended to be hypoechoic 
and adenocarcinoma tended to be isoechoic on ultrasound 
(8), and there was no significant difference in standardized 
uptake value max between SCC and non-SCC on 2-[18F] 
fluoro-2-deoxy-D-glucose positron emission tomography 
(9). Computed tomography (CT) is limited by poor soft 
tissue contrast, and magnetic resonance imaging (MRI) 
is superior to CT for local evaluation (10). Some types of 
adenocarcinomas show characteristic imaging findings, and 
the histopathological type can be suggested using MRI.
The MRI findings of a variety of cervical tumors can 
be grossly classified into five patterns (Fig. 1): Type 1, 
multicystic, or solid and cystic pattern; Type 2, exophytic 
villous pattern; Type 3, expansile solid pattern; Type 4, 
invasive solid pattern; and Type 5, diffuse infiltrative 
pattern. Some mainly show any one of these typical imaging 
patterns, while others can show mixed patterns. 
The purpose of this review is to discuss cervical 
adenocarcinomas and cervical lesions other than SCC from 
various aspects, including their association with high-risk 
HPV infection and their prognosis, and to demonstrate their 
representative MRI findings and patterns. 
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Cervical Adenocarcinoma
Endocervical Adenocarcinoma, Usual Type (Figs. 2, 3)
This is an invasive epithelial tumor showing glandular 
differentiation with relative mucin depletion. It is the most 
common type of cervical adenocarcinoma and accounts for 
approximately 90% of all adenocarcinomas. It is associated 
with high-risk HPV infection (Table 1) (1, 4, 5) and, 
potentially, long-term oral contraceptive use. The mean 
age at presentation is around 50 years (1). The prognosis 
of the usual type adenocarcinoma is similar to that of SCC 
(1-7). Macroscopically, approximately 50% tumors show 
an invasive growth pattern with an exophytic protrusion, 
and some show surface ulceration or a diffuse infiltrative 
pattern. Mucin-poor glands with cribriform and papillary 
structures are most often seen in histopathological 
analysis. Occasionally, cervical intraepithelial neoplasia 
(CIN) or adenocarcinoma in situ (AIS) coexists with this 
tumor, although they are frequently difficult to be detected 
radiologically. 
Fig. 1. MRI patterns of different cervical tumors. ASC = 
adenosquamous carcinoma, GAS = mucinous carcinoma gastric type, 
MRI = magnetic resonance imaging, NET = neuroendocrine tumor, SCC 
= squamous cell carcinoma, VGC = villoglandular carcinoma
Fig. 2. 56-year-old woman with endocervical adenocarcinoma, usual type.
A. Sagittal T2WI shows exophytic tumor (protruding inside canal) in cervical lip (arrow) and indicates invasive solid pattern (Fig. 1; Type 4). This 
is typical pattern for usual type adenocarcinoma. B. Sagittal contrast-enhanced fat-saturated T1WI shows weak enhancement of tumor (arrow). C. 
Sagittal DWI shows marked restricted diffusion (arrow). DWI = diffusion-weighted imaging, T1WI = T1-weighted imaging, T2WI = T2-weighted imaging
A B C
Table 1. Correlations of Different Uterine Cervical Tumorous 
Lesions with High-Risk HPV Infection
Adenocarcinoma HPV Infection
Endocervical adenocarcinoma, usual type +
Mucinous carcinoma
GAS -
Intestinal type +
Signet-ring cell type +/-
VGC +
Endometrioid carcinoma -
Clear cell carcinoma -
Serous carcinoma -
Mesonephric carcinoma -
Adenocarcinoma admixed with neuroendocrine tumor +
Other Tumors
Benign glandular tumors and tumor-like lesion 
LEGH, nabothian cyst, endocervical polyp -
Other epithelial tumors
Adenosquamous carcinoma +
Neuroendocrine tumor +
Mesenchymal tumors -
Lymphoid tumors
Lymphoma -
Secondary tumors -
GAS = mucinous carcinoma gastric type, HPV = human 
papillomavirus, LEGH = lobular endocervical glandular hyperplasia, 
VGC = villoglandular carcinoma
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An invasive solid pattern or a diffuse infiltrative pattern 
is commonly observed on MRI (Fig. 1; Types 4, 5), and it 
is generally difficult to distinguish these tumors from SCC 
using MRI alone. Sometimes, intratumoral cysts can be seen, 
but these are not common (11). The incidence of ovarian 
metastasis is higher with this type of adenocarcinoma than 
with SCC (12).
Mucinous Carcinoma, Gastric Type (Figs. 4, 5)
This is a mucinous adenocarcinoma that shows gastric 
type differentiation. Mucinous carcinoma gastric type (GAS) 
accounts for approximately 25% of all adenocarcinomas. 
GAS is not associated with high-risk HPV infection (Table 
1), so its incidence threatens to increase despite improved 
screening programs. The mean age at presentation is 
approximately 42 years and its prognosis is poorer than 
that of the usual type adenocarcinoma. The 5-year disease-
free survival rate is 30%, which is much lower than that of 
the usual type adenocarcinoma (74%) (1, 4). Its association 
with Peutz-Jeghers syndrome has been noted (1, 4). GAS 
includes minimal deviation adenocarcinoma (adenoma 
malignum). In addition, lobular endocervical glandular 
hyperplasia (LEGH), which is described later, is considered 
a precursor lesion of GAS according to recent studies (1, 4, 
13). Immunohistochemical studies are positive for makers 
of pyloric gland mucins (eg., MUC6, HIK1083) (4).
GAS typically appears as a multicystic lesion indicating 
LEGH with inner solid components on MRI, namely a solid 
and cystic pattern (Fig. 1; Type 1). Diffuse, solid low T2-
weighted signal intensities with an unclear margin in 
Fig. 3. 30-year-old woman with endocervical adenocarcinoma, usual type.
A. Sagittal T2WI shows exophytic tumor (arrow) in uterine cervix. Axial (B) and coronal (C) T2WIs show similar to fern leaf-like appearance, i.e., 
exophytic villous pattern (arrows) (Fig. 1; Type 2). D. Coronal DWI shows restricted diffusion (arrow). E, F. Fixed samples (E, coronal; F, sagittal) 
show diffuse enlargement of cervix, with invasive solid and diffuse infiltrative pattern, not exophytic villous pattern. G, H. On microscopic 
examination (G, hematoxylin-eosin staining, original magnification, x 40; H, hematoxylin-eosin staining, original magnification, x 200), tumor 
shows papillary surface, although it is composed of stromal hyperplasia caused by inflammation. Tumor cell glandules exist in inner part and show 
concave shape. Pseudostratification and necrotic debris within gland space are typical features of endocervical adenocarcinoma, usual type. 
Coexistence with CIN also indicates correlation with human papilloma virus infection. CIN = cervical intraepithelial neoplasia
A
E F G H
B C D
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LEGH, or a solid component with restricted diffusion in 
LEGH, suggests an occurrence of GAS (11, 13); however, 
sometimes, solid components are small, lack of restricted 
diffusion, and are difficult to distinguish from LEGH (13). 
In addition, tumors often diffusely infiltrate and invade 
more widely than expected on MRI.
Mucinous Carcinoma, Intestinal Type (Fig. 6)
This is a mucinous adenocarcinoma that shows area of 
intestinal-type differentiation. It accounts for about 2% 
of all cervical adenocarcinoma s and is associated with 
high-risk HPV infection (Table 1). Occasionally, the usual 
type adenocarcinoma coexists with this tumor depending 
on its association with high-risk HPV infection (1, 4). The 
intestinal differentiation shows typical mucinous-type 
epithelium and the most important differential diagnosis is 
A B C D
I J K L
E F G H
Fig. 4. 46-year-old woman with GAS (A-D: 1 year prior).
A, E. Sagittal T2WIs show multicystic mass with solid components (arrows) that increases in size. B, F. Axial T2WIs show solid components 
that have increased in size over year (arrows). Solid and cystic (Fig. 1; Type 1) as well as invasive solid patterns (Fig. 1; Type 4) are seen 
in this tumor. C, G. Axial contrast-enhanced fat-saturated T1WIs show mild enhancement of solid components (arrows). D, H. Restricted 
diffusion becomes clear on axial ADC map (arrows) over a year. I, J. Fixed samples (I, coronal; J, sagittal) show solid tumor with multiple cystic 
components. K. Microscopic examination (hematoxylin-eosin staining, original magnification, x 40) shows tumor cells diffusely infiltrating and 
involving glandules of LEGH lesion, while maintaining its glandular cavities. L. Microscopic examination (hematoxylin-eosin staining, original 
magnification, x 200) shows tumor cells with abundant clear cytoplasm. p16 negativity indicated lack of correlation with human papilloma virus 
infection (not displayed), which is characteristic of GAS. ADC = apparent diffusion coefficient, LEGH = lobular endocervical glandular hyperplasia
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metastasis from intestinal carcinoma. Immunohistochemical 
studies are positive for makers of intestinal mucins (e.g., 
CDX2) (4).
An invasive solid pattern or a diffuse infiltrative pattern 
is commonly observed on MRI (Fig. 1; Types 4, 5), and it 
generally shows relatively high signal intensities on T2-
weighted imaging (T2WI) and weak restricted diffusion 
reflecting intracellular mucinous components (14). 
Villoglandular Carcinoma (Fig. 7)
This is a variant of endocervical adenocarcinoma that 
shows a distinct exophytic, villous-papillary growth. It 
accounts for 3.7–4.8% of all cervical adenocarcinomas, and 
associated with high-risk HPV infection (Table 1). It affects 
younger individuals, and the mean age at presentation 
is approximately 35 years (1, 4). It has a good prognosis 
and fertility-preserving surgery may be considered if the 
tumor is in the early stage (1, 15). Occasionally, CIN or AIS 
coexists with this tumor depending on its association with 
high-risk HPV infection (1). 
A fern leaf-like appearance, i.e., an exophytic villous 
pattern (Fig. 1; Type 2), with restricted diffusion is a 
typical MRI finding of villoglandular carcinoma (VGC) (16).
Clear Cell Carcinoma (Fig. 8)
This adenocarcinoma is predominantly composed of clear 
or hobnail cells with solid, tubulocystic, and/or papillary 
architectural patterns. Microscopically, a solid tumor 
typically contains abundant glycogen-rich cytoplasm. It 
accounts for 2–4% of all cervical adenocarcinomas, and not 
associated with high-risk HPV infection (Table 1) (4, 5). In 
utero diethylstilbestrol exposure causes clear cell carcinoma 
in young patients with an average age of 19 years. However, 
the tumor now becomes rare, and most cases are sporadic 
A B C D
E F G H
Fig. 5. 56-year-old woman with GAS.
A. Sagittal T2WI shows multicystic mass (arrow) in uterine cervix, consistent with Type 1 appearance (Fig. 1). B. Sagittal contrast-enhanced fat-
saturated T1WI shows well enhanced septa in multicystic mass (arrow). C. Axial T2WI shows core-like hypointense lesion in center of multicystic 
mass (void arrow). D. Axial DWI shows restricted diffusion in solid core (void arrow), and solid component with restricted diffusion suggests GAS 
occurring in LEGH lesion. E, F. Fixed samples (E, coronal; F, sagittal) show multicystic tumor in uterine cervix. G, H. Microscopic examination (G, 
hematoxylin-eosin staining, original magnification, x 40; H, hematoxylin-eosin staining, original magnification, x 200) shows tumor composed of 
abundant mucinous lakes. Cluster of tumor cells exist in core, and tumor cells are widely spread to line mucinous lakes. p16 negativity indicated 
lack of correlation with human papilloma virus infection (not displayed).
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Fig. 6. 57-year-old woman with mucinous carcinoma, intestinal type.
Sagittal (A) and axial (B) T2WIs show high signal-intensity mass with invasive solid pattern (Fig. 1; Type 4) in uterine cervix (arrows). C. Tumor 
shows weak restricted diffusion on axial ADC map (arrow). Relatively high signal intensities on T2WI and weak restricted diffusion seem to 
reflecting intracellular mucinous components. D. Tumor is mildly enhanced on axial contrast-enhanced fat-saturated T1WI (arrow).
A B C D
A B C
Fig. 7. 36-year-old woman with villoglandular carcinoma.
Sagittal (A) and axial (B) T2WIs show cervical tumor with fern leaf-like appearance (exophytic villous pattern, Fig. 1; Type 2) (arrows). C. 
On axial DWI, tumor shows restricted diffusion (arrow), and malignancy is suggested. D. Fixed sample shows cervical tumor with fern leaf-like 
appearance. E, F. Microscopic examination (E, hematoxylin-eosin staining, original magnification, x 40; F, hematoxylin-eosin staining, original 
magnification, x 20) shows exophytic tumor with villous fronds lined by well-differentiated tumor cells. Coexistence with CIN also indicates 
correlation of this tumor with human papilloma virus infection.
D E F
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and involve older patients with an average age of 47 years 
(1). Clear cell carcinoma is clinically similar to the usual 
type adenocarcinoma, and its prognosis is also similar to 
that of the usual type adenocarcinoma (1).
It is difficult to distinguish clear cell carcinoma from SCC 
and the usual type adenocarcinoma using MRI alone (Fig. 1). 
Endometrioid Carcinoma (Fig. 9)
This adenocarcinoma arises in the cervix and exhibits 
endometrioid morphological features (1) and is not 
associated with high-risk HPV infection (Table 1) (4, 5). 
It is clinically and macroscopically similar to the usual 
type adenocarcinoma, and some researchers suggest 
that it is just a morphological variant of the usual type 
adenocarcinoma (1). 
Usually, it is difficult to distinguish endometrioid 
carcinoma from SCC and the usual type adenocarcinoma 
using MRI alone (Fig. 1). Moreover, the most important 
differential diagnosis is corpus endometrioid carcinoma 
extending to the cervix, which can be clinically 
misdiagnosed as cervical endometrioid carcinoma (1).
Other Cervical Tumors and Tumor-Like Lesions
Lobular Endocervical Glandular Hyperplasia (Fig. 10)
This is a distinct benign lobular proliferation of 
Fig. 8. 53-year-old woman with clear cell carcinoma.
Sagittal (A) and axial (B) T2WIs show invasive solid tumor (Fig. 1; Type 4) in uterine cervix (arrows) with right parametrial invasion reaching 
pelvic wall (void arrow). C. On axial DWI, tumor (arrow) and parametrical invasion (void arrow) both show restricted diffusion. It is difficult to 
distinguish clear cell carcinoma from SCC and endocervical adenocarcinoma, usual type, by MRI alone.
A B C
Fig. 9. 47-year-old woman with endometrioid carcinoma
Sagittal (A) and axial (B) T2WIs show invasive solid tumor (Fig. 1; Type 4) mainly located in cervical canal (arrows). Small tumor is also present 
in uterine corpus (void arrow). C. Sagittal contrast-enhanced fat-saturated T1WI shows mild enhancement of both tumors (arrow, void arrow). D. 
On axial DWI, tumor shows restricted diffusion (arrow). Pathological diagnosis was uterine corpus carcinoma, stage II, but final clinical diagnosis, 
which was based on main tumor location, was uterine cervical endometrioid carcinoma, stage IB2, with dissemination in uterine body cavity.
A B C D
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endocervical glands that commonly exhibits gastric/pyloric 
differentiation. Pyloric gland metaplasia is a synonym for 
LEGH. LEGH is considered a potential precursor lesion of 
GAS, and GAS or AIS occasionally coexists in LEGH lesions, 
necessitating careful attention in diagnosis. It may occur 
in women of reproductive age or postmenopausal women 
and watery or mucoid discharge is a characteristic clinical 
manifestation (1). 
Typically, it is located in the upper cervical canal. MRI 
findings of LEGH show two patterns, a cosmos pattern and a 
microcystic pattern. The cosmos pattern is characterized by 
central microcystic components surrounded by medium-sized 
to large cysts, while the microcystic pattern is characterized 
by the aggregation of small cysts without peripheral larger 
cysts. LEGH, particularly the microcystic pattern type, may 
be sometimes difficult to distinguish from GAS or AIS using 
MRI alone (13). 
In addition, other cystic lesions need to be differentiated 
from LEGH, such as Nabothian cyst, tunnel cluster, and 
endocervical polyp (13, 17), all of which are categorized 
as benign glandular tumors and tumor-like lesions in the 
fourth edition of the  World Health Organization (WHO) 
classification and not associated with high-risk HPV 
infection (Table 1) (1).
A B C
Fig. 10. 45-year-old woman with cosmos pattern LEGH (A, B) and 47-year-old woman with microcystic pattern LEGH (C).
Sagittal (A) and axial (B) T2WIs show multicystic lesion in uterine cervix (arrows) with Type 1 appearance (Fig. 1). Microcytic parts surrounded 
by medium-sized to large cysts, indicating cosmos pattern. C. Sagittal T2WI shows multicystic lesion in uterine cervix (arrow) (Fig. 1; Type 1). 
Aggregation of small cysts without peripheral large cysts, indicating microcystic pattern.
Fig. 11. 45-year-old woman with Nabothian cyst.
A. Sagittal T2WI shows multicystic lesion near surface of cervical lip (arrow). B. On axial T1WI, cysts show slightly high signal intensity (arrow). 
C. On axial T2WI, cysts show high to intermediate signal intensity (arrow). Intermediate signal intensities on T2WI and slightly high signal 
intensities on T1WI indicate mucus contents, and this is characteristic imaging finding of Nabothian cysts. D. There is no enhanced solid 
component in cysts (arrow) on axial contrast-enhanced fat-saturated T1WI.
A B C D
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Nabothian Cyst (Fig. 11)
This is a cystic structure in the cervical wall that is lined 
by normal endocervical epithelium and filled with mucus. 
A Nabothian cyst is a common finding, particularly in 
multiparous women (1). It is usually asymptomatic and 
often found incidentally on MRI. 
These cysts may be single or multiple, and they usually 
measure 2–10 cm in diameter. Generally, they are located 
near the surface of the endocervical canal, but they are 
occasionally found deep in the endocervical wall (1). The cyst 
is filled with mucus and characteristically exhibits high to 
intermediate signal intensities on T2WI and intermediate or 
slightly high signal intensities on T1-weighted imaging (17).
Endocervical Polyp (Fig. 12)
This is an exophytic lesion lined by benign endocervical 
epithelium covering a fibrovascular core. Sometimes a focus 
of in situ or invasive carcinoma can be contained within an 
endocervical polyp. It is one of the most common causes of 
intermenstrual vaginal bleeding (1). 
A multicystic structure with a fibrovascular core is a 
characteristic MRI finding (17).
A B C
Fig. 12. 53-year-old woman with cervical polyp.
Sagittal (A) and axial (B) T2WIs show exophytic, oval, multicystic lesion protruding from cervix into vagina (arrows). C. Sagittal contrast-
enhanced fat-saturated T1WI shows well-enhanced septa in multicystic lesion (arrow). Fibrovascular core is not clear; therefore, it is difficult to 
distinguish cervical polyp from LEGH in this case.
A B C
Fig. 13. 30-year-old woman with ASC.
Sagittal (A) and axial (B) T2WIs show invasive solid tumor (Fig. 1; Type 4) located in posterior cervical lip (arrows). C. Axial DWI shows markedly 
restricted diffusion (arrow). It is difficult to distinguish ASC from SCC and endocervical adenocarcinoma, usual type.
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Adenosquamous Carcinoma (Fig. 13)
This is a malignant tumor having both adenocarcinoma 
and SCC components, and the adenocarcinoma component 
should be adequately differentiated on the basis of 
histologically recognizable glands. Adenosquamous 
carcinoma (ASC) accounts for 3.6% of all cervical 
carcinomas, and usually be associated with high-risk HPV 
infection (Table 1) (4, 18). The mean age at presentation 
is approximately 50 years (6). Some studies have suggested 
a poorer prognosis than that of SCC and the usual type 
adenocarcinoma (4, 6, 7).
It is generally difficult to distinguish this entity from SCC 
and the usual type adenocarcinoma using MRI alone (Fig. 1).
Neuroendocrine Tumor (Fig. 14)
This tumor is similar to gastro-entero-pancreatic 
neuroendocrine tumors (NETs) and is divided into high-
grade and low-grade types. High-grade NETs are composed 
of high-grade malignant cells and may be either the small 
cell type or the large cell type. NETs are associated with 
high-risk HPV infection (Table 1), and may be accompanied 
by in situ or invasive SCC or adenocarcinoma. High-grade NETs 
are very aggressive, often accompanied by lymph node and 
distant metastasis and indicate a poor prognosis (19, 20).
MRI findings widely vary from the expansile solid pattern 
and the invasive solid pattern to the diffuse infiltrative 
pattern (Fig. 1; Types 3-5). Cervical NETs tend to appear 
as homogeneous lesions with multiple lymphadenopathies 
and are associated with a low apparent diffusion coefficient 
(ADC) (17, 21).
Leiomyoma (Fig. 15)
This is a benign tumor showing smooth muscle 
differentiation and containing a variable amount of 
collagen-rich extracellular matrix. It is categorized as a 
mesenchymal tumor and tumor-like lesion in the fourth 
edition of the WHO classification and not associated with 
high-risk HPV infection (Table 1) (1). Cervical leiomyoma 
is much rarer than leiomyoma involving the uterine body, 
and its frequency has been estimated to be 0.6% in 
hysterectomy specimens (22).
The lesion shows an expansile solid pattern (Fig. 1; 
Type 3) on MRI and typically appears as a well-defined, 
homogeneous, hypointense mass in the cervical stroma on 
T2WI, without restriction on diffusion-weighted imaging 
(DWI) (17, 23, 24).
Leiomyosarcoma (Fig. 16)
This is a malignant tumor showing smooth muscle 
differentiation. Primary sarcomas account for less than 1% 
of all malignant cervical tumors, and leiomyosarcoma is the 
most common type (22) and not associated with high-risk 
HPV infection (Table 1) (1).
MRI shows an expansile solid pattern or an invasive 
Fig. 14. 63-year-old woman with large cell neuroendocrine carcinoma.
Sagittal (A) and axial (B) T2WIs show invasive solid tumor (Fig. 1; Type 4) in uterine cervix (arrows). C. Axial DWI shows markedly restricted 
diffusion (arrow). This lesion is also difficult to distinguish from SCC and endocervical adenocarcinoma, usual type.
A B C
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Fig. 15. 70-year-old woman with leiomyoma. 
Sagittal (A) and axial (B) T2WIs show well-defined, homogeneous, hypointense mass (Fig. 1; Type 3) in stroma of uterine cervix (arrows). C. 
Axial DWI does not show restricted diffusion (arrow). 
A B C
solid pattern (Fig. 1; Types 3, 4). Leiomyosarcoma 
tends to show relatively high intensities on T2WI and 
restriction on DWI. Hemorrhage or necrosis and invasion of 
surrounding structures may be seen; these findings suggest 
leiomyosarcoma rather than leiomyoma (17, 23, 24).
Lymphoma (Fig. 17)
Primary or secondary lymphoma is a malignant neoplasm 
composed of lymphoid cells without association of high-
risk HPV infection (Table 1) (1). Uterine involvement 
is uncommon and primary lymphoma is much rarer. 
A B C
Fig. 16. 50-year-old woman with leiomyosarcoma. 
A. Sagittal T2WI shows invasive solid tumor (Fig. 1; Type 4) in myometrium of uterine cervix (arrow), with relatively high signal intensity. B. 
Sagittal T1WI shows foci of high signal intensity in tumor (arrow), which are considered to be hemorrhagic foci. C. Heterogeneous enhancement 
is seen in tumor (arrow) on sagittal contrast-enhanced fat-saturated T1WI. Nonenhanced areas indicate tumor necrosis with hemorrhage.
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The majority of primary uterine lymphomas are B-cell 
lymphomas. The primary lesions commonly involve the 
cervix and usually respond well to chemotherapy and 
radiotherapy and exhibit a favorable prognosis, while the 
secondary lesions involve either the corpus or the cervix 
and has worse prognosis (25, 26). 
MRI findings widely vary from an expansile solid pattern 
and an invasive solid pattern to a diffuse infiltrative 
pattern (Fig. 1; Types 3-5). Generally, diffuse enhancement 
and low ADC values are observed (17, 27).
A B C
Fig. 18. 80-year-old woman with urothelial carcinoma.
Sagittal (A) and axial (B) T2WIs show diffuse infiltrating mass (Fig. 1; Type 5) involving bladder (white arrows), left ureter (void arrows), 
parametrium, and uterine cervix. Bladder is mainly replaced with mass and urothelial carcinoma is speculated by MRI. C. On DWI, main tumor 
(white arrow) and bone metastasis show restricted diffusion (black arrow). Biopsy specimen from bladder shows urothelial carcinoma, which 
pathologically suggests that uterine cervix is secondarily involved by bladder cancer.
A B C
Fig. 17. 63-year-old woman with primary lymphoma of uterus, diffuse large B-cell type.
Sagittal (A) and axial (B) T2WIs show infiltrating masses (Fig. 1; Type 5) located in cervix and corpus (arrows). C. Tumors show markedly restricted 
diffusion (arrow) on axial DWI, suggesting rich cellularity.
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Secondary Tumors (Fig. 18)
Malignancies arising from structures surrounding the 
cervix, such as the uterine body, bladder, ureter, rectum, 
and ovary, can be misdiagnosed as primary uterine cervical 
cancer because of uterine cervix involvement (28). MRI is 
a useful tool for distinguishing secondary cervical tumors 
from the primary ones.
In summary, uterine cervical adenocarcinoma has a 
variety of histopathological subtypes. Among them, GAS 
and VGC show relatively characteristic imaging findings, 
and their histological types can be suggested using MRI. 
GAS is not associated with high-risk HPV infection, and its 
incidence threatens to increase. It exhibits a poor prognosis 
and should be distinguished from LEGH, though this 
differentiation can be sometimes difficult by MRI alone. 
VGC, on the other hand, has an association with high-risk 
HPV infection and a good prognosis compared with SCC 
and the usual type adenocarcinoma. Various kinds of other 
tumors should be also differentiated on MRI, while it is 
currently difficult to distinguish them and HPV screening 
and pathological confirmation are usually necessary for 
definite diagnosis and further patient management.
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